Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
indiana blog main
indiana top stories
2
×
life sciences
national blog main
new york blog main
new york top stories
type 1 diabetes
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech ipos
boehringer ingelheim
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
cigna
concert pharmaceuticals
cvs health
detroit blog main
What
drug
patients
type
2
×
advantages
approval
bar
bid
bio
boehringer
brings
diabetes
eli
expand
expect
fallen
fda
gamble
ingelheim
lilly
market
marketed
medco’s
medicine’s
mover
new
payers
physicians
plan
pricing
rejects
roundup
sets
short
ubiome
undone
vertex’s
Language
unset
2
×
Current search:
type
×
unset
×
" indiana top stories "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
